Healthcare Marketing
At Havas and Grey, I worked on a wide variety of HCP and DTC pharma accounts including the launch of Pristiq, Saphris, and a new indication of Cialis, as well as advancing other brands like Micardis, Krystexxa, Avonex, and Tysabri. At Interbrand Health, I collaborated on naming projects and brand evolutions for Quest Diagnostics, Terumo, and Regeneron. and Siemens.
Cialis expands into BPH
Cialis needed a campaign to promote its new benign prostatic hyperplasia (BPH) indication, growing its market beyond people suffering from ED.
How we did it
We explained the unique benefits of Cialis for BPH and ED, and created a market that could help patients suffering from one or both of these conditions.
Results
Cialis continued to be a market leader in the ED space while also becoming a first-line treatment for people with BPH.
